Yes, cystic fibrosis (CF) causes infertility in most men and subfertility in many women, but the two sexes are affected through different mechanisms and to very different degrees. In men, the near-universal absence of the vas deferens blocks sperm transport while sperm production itself usually remains intact. In women, thickened cervical mucus and delayed puberty reduce fertility, yet most can conceive, often with help.

The CFTR channel and why ducts fail

Cystic fibrosis is caused by variants in the CFTR gene, which builds a chloride and bicarbonate channel on the surface of epithelial cells. When CFTR fails, chloride cannot leave the cell and water follows it inward, so secretions stay thick and sticky instead of watery. Bicarbonate transport also drops, and that matters for fertility because bicarbonate is needed to activate sperm and to keep duct linings pliable.

In the male reproductive tract, the vas deferens, epididymis, and seminal vesicles form from the Wolffian duct during early fetal life. CFTR is expressed in these tissues, and thick secretions are thought to obstruct the forming duct and cause it to degenerate before birth. The result is congenital bilateral absence of the vas deferens (CBAVD), which means sperm are made in the testes but cannot reach the penis. This is an anatomical plumbing failure, not a hormone or sperm-production failure.

In women, CFTR sits on cervical mucus glands and on the lining of the reproductive tract. Faulty CFTR makes cervical mucus thick and scant, which physically impedes sperm swimming. CFTR also appears to influence ovulation and the uterine environment, though those effects are less well defined. The female tract is a series of open tubes rather than a single narrow duct, so obstruction rarely causes complete sterility.

The plain-language version: men with CF usually have working sperm factories but no delivery road, while women with CF usually have a working road that is partly clogged.

How often each sex is affected

Male infertility in CF is close to universal, while female subfertility is common but partial. The table below separates what is near-certain from what is variable.

Feature Men with CF Women with CF
Primary cause Absent or blocked vas deferens (CBAVD) Thick cervical mucus, ovulatory and nutritional factors
Frequency of infertility Most men; CBAVD is present in the large majority Subfertility common; absolute sterility uncommon
Sperm production Usually normal in the testes Not applicable
Sperm reach the ejaculate Absent in most Present but transport is impaired
Spontaneous conception Rare without assisted reproduction Possible for many, often delayed
Main assisted route Surgical sperm retrieval plus IVF/ICSI Ovulation support, cervical mucus management, IVF
Reversible factors None for the duct defect Nutrition, weight, diabetes control, infection

The asymmetry is the headline. A man with CF should assume his fertility is impaired until proven otherwise. A woman with CF should assume fertility is reduced but not absent, and she may conceive spontaneously, especially with good nutrition and lung function.

Male anatomy in detail: why sperm exist but never arrive

The vas deferens develops from the mesonephric duct, and CFTR-dependent fluid flow is required for that duct to stay open. When flow fails, the duct becomes atretic, meaning it narrows and disappears. Because this happens in fetal development, the defect is permanent. No medication reopens a duct that never formed.

Sperm production depends on the testes and on hormones from the pituitary, which are separate from the vas deferens. That is why men with CF typically have normal testosterone and active sperm production inside the testis. The problem shows up only when sperm must travel from testis to ejaculate, a journey of roughly 30 to 40 centimeters through the epididymis and vas deferens.

Some men with CF have a partially developed vas or a small remnant, and a minority have unilateral absence. CFTR variant type matters. Variants that leave residual channel function are associated with milder duct defects, and some men with CFTR-related disorders rather than classic CF have CBAVD as their only sign. This is the counterintuitive point: a man can be infertile from CFTR disease while having no lung or pancreatic symptoms at all.

About 1 to 2 percent of men with CBAVD have no detectable CFTR variant on standard testing, which means the genetic picture is not always complete. Genetic counseling before assisted reproduction is still essential because the partner's CFTR status affects the risk of a child with CF.

Female fertility in detail: mucus, ovulation, and the whole-body picture

Cervical mucus changes across the cycle, becoming thin and stretchy near ovulation to help sperm travel. In CF, mucus stays thick and may be scant, so sperm have a harder time crossing the cervix. The effect is partial, which is why some women with CF conceive without assistance.

CFTR is also present on the endometrium and in the oviduct, and bicarbonate-rich fluid appears to support sperm capacitation, the final maturation step before fertilization. When bicarbonate is low, that step may be less efficient. Ovulation itself can be disrupted in CF because chronic illness, low body weight, and diabetes affect the hormonal axis.

Nutrition is the modifiable link. Women with CF and low body mass index often have irregular cycles or stop ovulating, similar to other states of low energy availability. CF-related diabetes adds another layer, because poor glucose control can disturb ovulation and raise pregnancy risks. Treating nutrition and diabetes can restore ovulation in some women, which is why a fertility workup in CF should start with metabolic control rather than a referral straight to IVF.

The professional caveat: much of the evidence for direct CFTR effects on ovulation and the uterus comes from small studies and animal models. The cervical mucus effect is well established, but the relative contribution of each pathway in women is not precisely quantified.

Red flags that change the workup

No puberty by age 14 in a boy, or delayed puberty in a girl, warrants CFTR evaluation. A man with CBAVD and no lung symptoms still needs CFTR genetic testing and counseling. A woman with CF and absent periods needs evaluation for low weight, diabetes, or chronic infection before fertility treatment. Sudden fertility decline in either sex should prompt review of infections, medications, and metabolic control. A couple with CF-related infertility should get genetic counseling before any assisted reproduction.

Misconceptions worth correcting

The most common error is assuming CF makes men sterile because their sperm are bad. In most cases the sperm are fine; they simply cannot exit. That distinction matters because it means surgical sperm retrieval can often find usable sperm.

A second error is assuming women with CF cannot get pregnant. Many can, and some conceive without treatment, so contraception counseling is as important as fertility counseling.

A third error is treating CF infertility as identical in both sexes. The mechanisms, success rates, and counseling differ enough that a single "CF causes infertility" statement misleads.

A fourth error is ignoring mild CFTR variants. Some men with CBAVD carry one severe and one mild variant and have no classic CF symptoms, which is why CFTR testing belongs in male infertility workups even without respiratory disease.

Practical actions and thresholds

Men with CF should assume fertility is impaired and seek reproductive urology evaluation before trying to conceive. A semen analysis showing low volume and absent sperm is expected; the next step is genetic testing and discussion of surgical sperm retrieval with IVF-ICSI.

Women with CF who want to conceive should optimize nutrition and glucose control first. A body mass index below roughly 18.5 and poor glycemic control are reversible contributors to subfertility. Preconception review should cover lung function, medications, and infection status, because pregnancy adds cardiac and respiratory demand.

Couples should request CFTR genetic testing for both partners before assisted reproduction. If both carry CFTR variants, the risk of an affected child rises substantially and can be addressed through prenatal testing or embryo screening.

Timing matters. Fertility decline with age compounds CF-related subfertility, so women with CF who want children should not delay evaluation. Men have more time but should still plan because sperm retrieval and IVF take months.

Timeline of reproductive events in CF

Stage What happens Fertility implication
Fetal development Wolffian duct forms and may obstruct Vas deferens may fail to develop
Birth to puberty No reproductive symptoms usually Defect is silent
Puberty Secondary sex characteristics develop normally in most Sperm production begins but transport is blocked
Adolescence Delayed puberty possible in both sexes Temporary or persistent subfertility
Adulthood CBAVD confirmed in most men Assisted reproduction usually required
Preconception Nutrition and glucose review Modifiable factors addressed
Pregnancy Respiratory and metabolic demands rise Specialist monitoring needed

Limits of the evidence and what remains uncertain

The male pathway is well characterized because CBAVD is visible and consistent. The female pathway is messier, with cervical, ovulatory, and uterine contributions that are hard to separate in small cohorts.

Most CF fertility data come from specialty clinics rather than population registries, so true conception rates without assistance are uncertain. Numbers vary by CFTR variant, pancreatic status, and access to care, and modern modulator therapies may change reproductive outcomes over time, though that evidence is still maturing.

What can be said with confidence is directional: CF causes near-universal male infertility through duct failure and common but partial female subfertility through mucus and metabolic factors. Anyone with CF who wants children should seek preconception counseling early rather than assume the answer either way.